Loading company
Co-Diagnostics, Inc.
CODX · Nasdaq · Healthcare · Medical Devices
$1.09-5.2%Sep 25 close
- 1M
- -9.9%
- 6M
- -37.7%
- 1Y
- -90.2%
- 5Y
- -99.6%
CODX · Nasdaq · Healthcare · Medical Devices
$1.09-5.2%Sep 25 close
The quarter ending June 30, 2026, against the same quarter a year earlier.
| Measure | 3 months toJun 30, 2026 | 3 months toJun 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $166.1K | $162.9K | +1.98% |
| Profit | -$6.3M | -$7.7M | +18.71% |
| Profit per share | -$1.46 | -$7.05 | +79.29% |
| Free Cash Flow | -$7.2M | -$8.7M | +17.47% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Co-Diagnostics, Inc. has no earnings call transcript available.